[{"address1": "Weihai Torch Hi-Tech Science Park", "address2": "No. 1, Weihai Road", "city": "Weihai", "country": "China", "website": "https://www.weigaogroup.com", "industry": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and  blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.", "fullTimeEmployees": 12606, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jing  Long", "age": 48, "title": "Executive Chairman of the Board & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 420345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rinan  Cong", "age": 42, "title": "Chief Executive Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 313399, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Junqiang  Lu", "age": 49, "title": "Executive Director", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 147787, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Xue Feng  Wu", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Xia  Yan", "age": 48, "title": "Non-Executive Director", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daoming  Wang", "age": 44, "title": "Executive Director", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Miu Ling  Wong ACIS, FCIS, FCS", "age": 54, "title": "Company Secretary", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 3, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 9, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.09, "open": 2.09, "dayLow": 2.03, "dayHigh": 2.09, "regularMarketPreviousClose": 2.09, "regularMarketOpen": 2.09, "regularMarketDayLow": 2.03, "regularMarketDayHigh": 2.09, "dividendRate": 0.09, "dividendYield": 0.0456, "exDividendDate": 1721606400, "payoutRatio": 0.1785, "fiveYearAvgDividendYield": 1.73, "beta": 0.428, "trailingPE": 8.583333, "volume": 13544, "regularMarketVolume": 13544, "averageVolume": 10258, "averageVolume10days": 34130, "averageDailyVolume10Day": 34130, "bid": 2.11, "ask": 2.36, "bidSize": 40000, "askSize": 40000, "marketCap": 2331219712, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 4.13, "priceToSalesTrailing12Months": 0.17977484, "fiftyDayAverage": 1.9984, "twoHundredDayAverage": 2.6401, "trailingAnnualDividendRate": 0.186, "trailingAnnualDividendYield": 0.08899522, "currency": "USD", "enterpriseValue": 7235029504, "profitMargins": 0.14741999, "floatShares": 2420789704, "sharesOutstanding": 1130579968, "bookValue": 5.049, "priceToBook": 0.4080016, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": -0.075, "netIncomeToCommon": 1911687936, "trailingEps": 0.24, "enterpriseToRevenue": 0.558, "enterpriseToEbitda": 2.449, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "SHWGY", "underlyingSymbol": "SHWGY", "shortName": "SHANDONG WEIGAO GROUP MEDICAL U", "longName": "Shandong Weigao Group Medical Polymer Company Limited", "firstTradeDateEpochUtc": 1334755800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c4f50c70-cebf-3351-8460-09bf43b7ebd7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.06, "recommendationKey": "none", "totalCash": 7866556928, "totalCashPerShare": 1.721, "ebitda": 2954725888, "totalDebt": 4129118976, "quickRatio": 2.566, "currentRatio": 3.279, "totalRevenue": 12967441408, "debtToEquity": 16.763, "revenuePerShare": 11.508, "returnOnAssets": 0.03771, "returnOnEquity": 0.08181, "freeCashflow": 1033357504, "operatingCashflow": 2704152064, "earningsGrowth": -0.097, "revenueGrowth": -0.038, "grossMargins": 0.49692002, "ebitdaMargins": 0.22785999, "operatingMargins": 0.19034, "financialCurrency": "CNY", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]